β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance

β-adrenergic signaling is known to be involved in cancer progression; in particular, beta3-adrenoreceptor (β3-AR) is associated with different tumor conditions. Currently, there are few data concerning β3-AR in myeloid malignancies. Here, we evaluated β3-AR in myeloid leukemia cell lines and the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvani, Maura, Dabraio, Annalisa, Bruno, Gennaro, De Gregorio, Veronica, Coronnello, Marcella, Bogani, Costanza, Ciullini, Sara, la Marca, Giancarlo, Vignoli, Marina, Chiarugi, Paola, Nardi, Margherita, Vannucchi, Alessandro Maria, Filippi, Luca, Favre, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352890/
https://www.ncbi.nlm.nih.gov/pubmed/32545695
http://dx.doi.org/10.3390/ijms21124210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352890/
https://www.ncbi.nlm.nih.gov/pubmed/32545695
http://dx.doi.org/10.3390/ijms21124210

Ejemplares similares